|
|
|
|
|
|
Sponsors and Collaborators: |
Taichung Veterans General Hospital Taipei Veterans General Hospital,Taiwan Changhua Christian Hospital |
Information provided by: | Taichung Veterans General Hospital |
ClinicalTrials.gov Identifier: | NCT00417729 |
To compare effect of acarbose versus glibenclamide treatment on mean amplitude of glyclemic excursion and oxidative stress in diabetes individuals who failed to control their glucose by metformin therapy alone
Condition | Intervention | Phase |
Diabetes Mellitus |
Drug: Acarbose, Glibenclamide, Metformin |
Phase IV |
MedlinePlus related topics: | Diabetes Stress |
Drug Information available for: | Glyburide Metformin Metformin hydrochloride Acarbose |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Estimated Enrollment: | 120 |
Study Start Date: | January 2007 |
Ages Eligible for Study: | 30 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients may be included in the clinical trial only if they meet all of the following criteria:
Exclusion Criteria:
Patients will be excluded from the clinical trial for any of the following reasons:
Contact: Wayne H Sheu, MD, PhD | 886-4-23592525 ext 3068 | whhsheu@vghtc.gov.tw |
Taiwan | |||||
Taichung Veterans General Hospital | Recruiting | ||||
Taichung, Taiwan | |||||
Contact: Wayne H Sheu, MD, PhD 886-4-23592525 ext 3068 whhsheu@vghtc.gov.tw | |||||
Sub-Investigator: I Te Lee, MD, MS |
Taichung Veterans General Hospital |
Taipei Veterans General Hospital,Taiwan |
Changhua Christian Hospital |
Principal Investigator: | Wayne H Sheu, MD, PhD | Taichung Veterans General Hospital |
Study ID Numbers: | IRB951004/C06211 |
First Received: | January 1, 2007 |
Last Updated: | January 1, 2007 |
ClinicalTrials.gov Identifier: | NCT00417729 |
Health Authority: | Taiwan: Department of Health |
|
|
|
|
|